The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Minireview: Cyclin D1: Normal and Abnormal Functions
Abstract
Cyclin D1 encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1-S phase of the cell cycle. Amplification or overexpression of cyclin D1 plays pivotal roles in the development of a subset of human cancers including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer. Of the three D-type cyclins, each of which binds cyclin-dependent kinase (CDK), it is cyclin D1 overexpression that is predominantly associated with human tumorigenesis and cellular metastases. In recent years accumulating evidence suggests that in addition to its original description as a CDK-dependent regulator of the cell cycle, cyclin D1 also conveys cell cycle or CDK-independent functions. Cyclin D1 associates with, and regulates activity of, transcription factors, coactivators and corepressors that govern histone acetylation and chromatin remodeling proteins. The recent findings that cyclin D1 regulates cellular metabolism, fat cell differentiation and cellular migration have refocused attention on novel functions of cyclin D1 and their possible role in tumorigenesis. In this review, both the classic and novel functions of cyclin D1 are discussed with emphasis on the CDK-independent functions of cyclin D1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationThe cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. T., & Stanley, E. R. (1985) · Cell · doi:10.1016/s0092-8674(85)80047-7 · Cited by 1,540
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,409
Molecular Regulation of Adipogenesis
Rosen, E. D., & Spiegelman, B. M. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.145 · Cited by 1,285
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Felsenfeld, G., & Groudine, M. (2003) · Nature · doi:10.1038/nature01411 · Cited by 1,150
Cited by
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Alao, J. P. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-24 · Cited by 871
The Molecular Clock Mediates Leptin-Regulated Bone Formation
Fu, L., Patel, M. S., Bradley, A., Wagner, E. F., & Karsenty, G. (2005) · Cell · doi:10.1016/j.cell.2005.06.028 · Cited by 578
Lange, C., Huttner, W. B., & Calegari, F. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.026 · Cited by 565
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes
Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn522 · Cited by 477
High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics
Carvalho, C. M., Chang, J., Lucas, J. E., Nevins, J. R., Wang, Q., & West, M. (2008) · Journal of the American Statistical Association · doi:10.1198/016214508000000869 · Cited by 471
Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 469
Jares, P., Colomer, D., & Campo, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2230 · Cited by 466
Molecular pathogenesis of mantle cell lymphoma
Jares, P., Colomer, D., & Campo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61272 · Cited by 382
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation
Yu, Z., Wang, C., Wang, M., Li, Z., Casimiro, M. C., Liu, M., Wu, K., Whittle, J., Ju, X., Hyslop, T., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801079 · Cited by 363
Self-citationTranscriptional regulation of the cyclin D1 gene at a glance
Klein, E. A., & Assoian, R. K. (2008) · Journal of Cell Science · doi:10.1242/jcs.039131 · Cited by 341
The Requirement for Cyclin D Function in Tumor Maintenance
Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., Signoretti, S., Look, A. T., Kung, A. L., von Boehmer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.015 · Cited by 342
“Moreover, in many human cancers overexpression of D-type cyclins takes place in the absence of any detectable genomic alterations (Deshpande et al., 2005; Fu et al., 2004; Musgrove et al. 2011).”
BackgroundInfluentialLacasa, D., Taleb, S., Keophiphath, M., Miranville, A., & Clement, K. (2007) · Endocrinology · doi:10.1210/en.2006-0687 · Cited by 334
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Itoh, S., Kim, H. W., Nakagawa, O., Ozumi, K., Lessner, S. M., Aoki, H., Akram, K., McKinney, R. D., Ushio-Fukai, M., & Fukai, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709463200 · Cited by 317
Tight junctions and the regulation of gene expression
Balda, M. S., & Matter, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.024 · Cited by 308
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
Sun, M., Jin, F.-Y., Xia, R., Kong, R., Li, J.-H., Xu, T.-P., Liu, Y.-W., Zhang, E.-B., Liu, X.-H., & De, W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-319 · Cited by 298
Leslie, K., Lang, C., Devgan, G., Azare, J., Berishaj, M., Gerald, W., Kim, Y. B., Paz, K., Darnell, J. E., Albanese, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2203 · Cited by 285
Self-citationFu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T.-P., & Pestell, R. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500403200 · Cited by 276
Self-citationCell cycle control of mammalian neural stem cells: putting a speed limit on G1
Salomoni, P., & Calegari, F. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.006 · Cited by 270
GSK-3β regulates cyclin D1 expression: A new target for chemotherapy
Takahashi-Yanaga, F., & Sasaguri, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.018 · Cited by 261
Allam, R. M., Al-Abd, A. M., Khedr, A., Sharaf, O. A., Nofal, S. M., Khalifa, A. E., Mosli, H. A., & Abdel-Naim, A. B. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.008 · Cited by 259
Growth control by intracellular tension and extracellular stiffness
Assoian, R. K., & Klein, E. A. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.05.002 · Cited by 258
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight
Brisken, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3518 · Cited by 255
Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204
Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells
Almeida, M. I., Nicoloso, M. S., Zeng, L., Ivan, C., Spizzo, R., Gafà, R., Xiao, L., Zhang, X., Vannini, I., Fanini, F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.047 · Cited by 202
Pestell, R. G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.001 · Cited by 197
Self-citationEWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115
Self-citationNegative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins
Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2236 · Cited by 72
“activation of several transcription factors by cyclin D have been described (19).”
BackgroundDifferential disruption of cell cycle pathways in small cell and non-small cell lung cancer
Coe, B. P., Lockwood, W. W., Girard, L., Chari, R., MacAulay, C., Lam, S., Gazdar, A. F., Minna, J. D., & Lam, W. L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603167 · Cited by 67
Fu, X., Tan, D., Hou, Z., Hu, Z., & Liu, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078514 · Cited by 54
“CyclinD1 is a member of the G1 phase family of cyclins that are modulated by extra- or intracellular mitotic signals and promotes the progression of the cell cycle from the G1 to S phase through the activation of cyclin-dependent kinases (CDK), namely CDK4 and CDK6 [28].”
BackgroundAllan, G., Ouadid-Ahidouch, H., Sanchez-Fernandez, E. M., Risquez-Cuadro, R., Fernandez, J. M. G., Ortiz-Mellet, C., & Ahidouch, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076411 · Cited by 45
“Indeed, cyclin D1 plays an important role in controlling the G0/G1 progression and G1/S transition of the cell cycle by activating their cyclin–dependent kinases (CDK4 and CDK2) and cyclin E, which leads to phosphorylation of the retinoblastoma protein (pRb) and, in turn, let the cells to progress through the G1 phase…”
Background(2007) · PubMed · Cited by 39
Evaluation of cyclin D1 expression and its subcellular distribution in mouse tissues
De Falco, M., Fedele, V., De Luca, L., Penta, R., Cottone, G., Cavallotti, I., Laforgia, V., & De Luca, A. (2004) · Journal of Anatomy · doi:10.1111/j.0021-8782.2004.00347.x · Cited by 38
Metadata
- Authors
- Fu, M., Wang, C., Li, Z., Sakamaki, T., & Pestell, R. G.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-12-01
- Volume
- 145
- Issue
- 12
- Pages
- 5439-5447
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2080677621
- Cited by
- 966
- References
- 116
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.